When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4 lymphocyte counts <350 cells/µL

John G. Bartlett

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4 lymphocyte counts <350 cells/µL'. Together they form a unique fingerprint.